Novacyt (ALNOV) - Total Liabilities

Latest as of December 2025: €16.94 Million EUR ≈ $19.81 Million USD

Based on the latest financial reports, Novacyt (ALNOV) has total liabilities worth €16.94 Million EUR (≈ $19.81 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Novacyt - Total Liabilities Trend (2008–2025)

This chart illustrates how Novacyt's total liabilities have evolved over time, based on quarterly financial data. See ALNOV working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Novacyt Competitors by Total Liabilities

The table below lists competitors of Novacyt ranked by their total liabilities.

Company	Country	Total Liabilities
Mindax Ltd AU:MDX	Australia	AU$1.90 Million
Freemelt Holding AB ST:FREEM	Sweden	Skr19.93 Million
Kartal Yenilenebilir Enerji Uretim AS IS:KARYE	Turkey	TL931.18 Million
Co2 Capsol AS OL:CAPSL	Norway	Nkr89.69 Million
Avonmore Capital & Management Services Limited NSE:AVONMORE	India	Rs757.90 Million
Manx Financial Group PLC F:3IM	Germany	€466.11 Million
KNW Co. Ltd KQ:105330	Korea	₩104.16 Billion
Fusemachines Inc. Common stock NASDAQ:FUSE	USA	$22.11 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Novacyt's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Novacyt.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novacyt's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novacyt (2008–2025)

The table below shows the annual total liabilities of Novacyt from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	€16.94 Million ≈ $19.81 Million	-25.54%
2024-12-31	€22.75 Million ≈ $26.60 Million	-51.15%
2023-12-31	€46.57 Million ≈ $54.45 Million	+81.32%
2022-12-31	€25.68 Million ≈ $30.03 Million	-38.67%
2021-12-31	€41.88 Million ≈ $48.96 Million	-49.88%
2020-12-31	€83.57 Million ≈ $97.70 Million	+493.86%
2019-12-31	€14.07 Million ≈ $16.45 Million	+26.14%
2018-12-31	€11.16 Million ≈ $13.04 Million	+37.94%
2017-12-31	€8.09 Million ≈ $9.45 Million	-25.14%
2016-12-31	€10.80 Million ≈ $12.63 Million	+122.45%
2015-12-31	€4.86 Million ≈ $5.68 Million	+2.56%
2014-12-31	€4.74 Million ≈ $5.54 Million	+555.79%
2013-12-31	€722.07K ≈ $844.18K	-63.13%
2012-12-31	€1.96 Million ≈ $2.29 Million	-2.26%
2011-12-31	€2.00 Million ≈ $2.34 Million	-27.02%
2010-12-31	€2.75 Million ≈ $3.21 Million	+6.77%
2009-12-31	€2.57 Million ≈ $3.01 Million	+34.66%
2008-12-31	€1.91 Million ≈ $2.23 Million	--

About Novacyt

PA:ALNOV France Medical Devices

Market Cap

$33.38 Million

€28.55 Million EUR

Market Cap Rank

#23460 Global

#372 in France

Share Price

€0.39

Change (1 day)

-3.43%

52-Week Range

€0.32 - €0.90

All Time High

€13.24